Drug Trial Radar · NCT06386146
JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
144
Planned (sponsor's estimate)
Start
Jul 24, 2024
Primary completion
Jan 2027
Study completion Jul 2027
Sponsor
- Lead sponsor
- Jacobio Pharmaceuticals Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is to evaluate the efficacy and safety of JAB-30355 in adult participants with advanced solid tumors harboring TP53 Y220C mutation.
Conditions
- Solid Tumors
Interventions
JAB-30355Drug
Oral administration
JAB-30355Drug
Oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dose limiting toxicity (DLT)Time frame: Approximately one year
- Number of participants with adverse eventsTime frame: Approximately three years
Locations
15 sites in 2 countries. Site status is shown where the registry gives one.
Research Site
Denver, Colorado · Recruiting
Research site
Lake Mary, Florida · Terminated
Research site
St Louis, Missouri · Recruiting
Research site
Canton, Ohio · Terminated
Research site
Cleveland, Ohio · Recruiting
Research Site
Nashville, Tennessee · Recruiting
Research site
Houston, Texas · Recruiting
Research Site
Beijing, Beijing Municipality, China · Recruiting
Research Site
Beijing, Beijing Municipality, China · Recruiting
Research Site
Beijing, Beijing Municipality, China · Recruiting
Research Site
Guangzhou, Guangdong, China · Recruiting
Research Site
Zhengzhou, Henan, China · Recruiting
Research Site
Shenyang, Liaoning, China · Recruiting
Research Site
Jinan, Shandong, China · Recruiting
Research Site
Shanghai, Shanghai Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.